Cencora Stock Revenue
| COR Stock | USD 258.07 0.00 0.00% |
Cencora fundamentals help investors to digest information that contributes to Cencora's financial success or failures. It also enables traders to predict the movement of Cencora Stock. The fundamental analysis module provides a way to measure Cencora's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cencora stock.
| Last Reported | Projected for Next Year | ||
| Total Revenue | 338.1 B | 355 B |
Cencora | Revenue |
Cencora Company Revenue Analysis
Cencora's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Cencora Revenue | 293.96 B |
Most of Cencora's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cencora is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Historical and Projected quarterly revenue of Cencora
Projected quarterly revenue analysis of Cencora provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of Cencora match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in Cencora's stock price.
Cencora Revenue Driver Correlations
Understanding the fundamental principles of building solid financial models for Cencora is extremely important. It helps to project a fair market value of Cencora Stock properly, considering its historical fundamentals such as Revenue. Since Cencora's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Cencora's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Cencora's interrelated accounts and indicators.
| -0.32 | -0.32 | 0.05 | -0.27 | 0.11 | ||
| -0.32 | 1.0 | -0.19 | 0.97 | 0.13 | ||
| -0.32 | 1.0 | -0.19 | 0.97 | 0.13 | ||
| 0.05 | -0.19 | -0.19 | -0.27 | -0.11 | ||
| -0.27 | 0.97 | 0.97 | -0.27 | 0.13 | ||
| 0.11 | 0.13 | 0.13 | -0.11 | 0.13 |
Click cells to compare fundamentals
Cencora Revenue Historical Pattern
Today, most investors in Cencora Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Cencora's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's revenue growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Cencora revenue as a starting point in their analysis.
Cencora Revenue |
| Timeline |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Cencora Current Deferred Revenue
Current Deferred Revenue |
|
Based on the latest financial disclosure, Cencora reported 293.96 B of revenue. This is much higher than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The revenue for all United States stocks is significantly lower than that of the firm.
Cencora Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cencora's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cencora could also be used in its relative valuation, which is a method of valuing Cencora by comparing valuation metrics of similar companies.Cencora is currently under evaluation in revenue category among its peers.
Cencora ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Cencora's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Cencora's managers, analysts, and investors.Environmental | Governance | Social |
Cencora Institutional Holders
Institutional Holdings refers to the ownership stake in Cencora that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Cencora's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Cencora's value.| Shares | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 3 M | Capital Research Global Investors | 2024-12-31 | 2.9 M | Northern Trust Corp | 2024-12-31 | 2.4 M | Pacer Advisors, Inc. | 2024-12-31 | 2.2 M | Bessemer Group Inc | 2024-12-31 | 2.2 M | Norges Bank | 2024-12-31 | 2.1 M | Fmr Inc | 2024-12-31 | 1.8 M | Ubs Asset Mgmt Americas Inc | 2024-12-31 | 1.6 M | Goldman Sachs Group Inc | 2024-12-31 | 1.6 M | Vanguard Group Inc | 2024-12-31 | 21.3 M | Walgreens Boots Alliance Inc | 2024-12-31 | 20 M |
Cencora Fundamentals
| Return On Equity | 1.98 | ||||
| Return On Asset | 0.0286 | ||||
| Profit Margin | 0 % | ||||
| Operating Margin | 0.01 % | ||||
| Current Valuation | 54.92 B | ||||
| Shares Outstanding | 193.71 M | ||||
| Shares Owned By Insiders | 6.85 % | ||||
| Shares Owned By Institutions | 92.62 % | ||||
| Number Of Shares Shorted | 6.94 M | ||||
| Price To Earning | 82.16 X | ||||
| Price To Book | 220.63 X | ||||
| Price To Sales | 0.16 X | ||||
| Revenue | 293.96 B | ||||
| Gross Profit | 9.9 B | ||||
| EBITDA | 3.25 B | ||||
| Net Income | 1.52 B | ||||
| Cash And Equivalents | 2.59 B | ||||
| Cash Per Share | 0.08 X | ||||
| Total Debt | 4.39 B | ||||
| Current Ratio | 0.58 X | ||||
| Book Value Per Share | 1.17 X | ||||
| Cash Flow From Operations | 3.48 B | ||||
| Short Ratio | 4.18 X | ||||
| Earnings Per Share | 7.05 X | ||||
| Price To Earnings To Growth | 1.00 X | ||||
| Target Price | 279.69 | ||||
| Number Of Employees | 46 K | ||||
| Beta | 0.5 | ||||
| Market Capitalization | 49.99 B | ||||
| Total Asset | 67.1 B | ||||
| Retained Earnings | 5.42 B | ||||
| Working Capital | (6.56 B) | ||||
| Current Asset | 19.09 M | ||||
| Current Liabilities | 111.82 M | ||||
| Annual Yield | 0.01 % | ||||
| Five Year Return | 3.65 % | ||||
| Net Asset | 67.1 B | ||||
| Last Dividend Paid | 2.08 |
About Cencora Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cencora's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cencora using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cencora based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Cencora
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cencora position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cencora will appreciate offsetting losses from the drop in the long position's value.Moving against Cencora Stock
| 0.83 | OM | Outset Medical | PairCorr |
| 0.72 | EMBC | Embecta Corp | PairCorr |
| 0.69 | EUDA | EUDA Health Holdings | PairCorr |
| 0.65 | EKSO | Ekso Bionics Holdings | PairCorr |
| 0.64 | VREX | Varex Imaging Corp | PairCorr |
The ability to find closely correlated positions to Cencora could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cencora when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cencora - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cencora to buy it.
The correlation of Cencora is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cencora moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cencora moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cencora can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Cencora Stock Analysis
When running Cencora's price analysis, check to measure Cencora's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cencora is operating at the current time. Most of Cencora's value examination focuses on studying past and present price action to predict the probability of Cencora's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cencora's price. Additionally, you may evaluate how the addition of Cencora to your portfolios can decrease your overall portfolio volatility.